Hyperbaric oxygen therapy for medical healing.

HBOT is FDA-recognized and UHMS-approved for these conditions (see the full reference list below):

• Compromised skin grafts and flaps
• Non-healing problem wounds, including qualifying diabetic foot ulcers
• Delayed radiation injury (soft-tissue and bony necrosis following cancer therapy)
• Chronic refractory osteomyelitis (persistent bone infection)
• Severe thermal burns
• Necrotizing soft-tissue infections and gas gangrene
• Crush injury and acute traumatic ischemias
• Carbon monoxide poisoning, air/gas embolism, decompression sickness
• Sudden sensorineural hearing loss; central retinal artery occlusion
• Severe anemia (when transfusion isn't possible)
• Avascular necrosis (newest recognized indication)

For these recognized uses, HBOT has established clinical evidence. Coverage note: Sync is out-of-network; see pricing for superbill and self-pay details.

Beyond the recognized list, many people ask about HBOT for other conditions. Here the evidence ranges from promising to preliminary — we'll always tell you which. A physician evaluation determines whether HBOT makes sense for your situation.

• Diabetes-related complications & neuropathyEmerging

  Many people with diabetes explore HBOT beyond the recognized foot-ulcer indication.

• Sports & muscle injuriesEmerging

  Many athletes explore HBOT to support recovery from muscle injury. Emerging for injury recovery; not shown to boost performance — see our article.

• Head trauma & post-concussion symptomsEmerging

  A growing number of people explore HBOT after brain injury. Read the honest evidence.

• Neurological & cognitive conditions (incl. Alzheimer's-type concerns, stroke recovery)Investigational

  Some people explore HBOT for cognitive and neurological concerns. Evidence is early.

Each item links (in Learn) to the matching blog article so the reader sees the graded evidence, not a promise.

Air or gas embolism · Carbon monoxide poisoning · Gas gangrene (clostridial myonecrosis) · Crush injury & acute traumatic ischemias · Decompression sickness · Arterial insufficiencies (incl. central retinal artery occlusion; selected problem wounds) · Severe anemia · Intracranial abscess · Necrotizing soft-tissue infections · Refractory osteomyelitis · Delayed radiation injury (soft-tissue & osteoradionecrosis) · Compromised grafts and flaps · Acute thermal burns · Sudden sensorineural hearing loss · Avascular necrosis (newest addition)

UHMS-approved / FDA-recognized indications (15th ed.). Presented as reference; each is a Tier-1 indication with established clinical evidence.